uniQure Announces Clinical Data Presentations at the 61st American Society of Hematology (ASH) Annual Meeting LEXINGTON, Mass. and AMSTERDAM, the Netherlands, Nov. 06, 2019 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with...